...
首页> 外文期刊>Bulletin of the Korean Chemical Society >Influence of Hydroxypropylmethylcellulose and Sodium Lauryl Sulfate on the Solubility and Dissolution of Sirolimus in Solvent‐evaporated Solid Dispersions
【24h】

Influence of Hydroxypropylmethylcellulose and Sodium Lauryl Sulfate on the Solubility and Dissolution of Sirolimus in Solvent‐evaporated Solid Dispersions

机译:羟丙基甲基纤维素和十二烷基硫酸钠对西罗莫司在溶剂蒸发的固体分散体中的溶解度和溶解度的影响

获取原文

摘要

The object of this study was to investigate the influence of hydroxypropylmethylcellulose (HPMC) and sodium lauryl sulfate (SLS) on the solubility, dissolution, and crystallinity of poorly water‐soluble sirolimus in solvent‐evaporated solid dispersions. For the selection of suitable carriers, the influence of carriers on the solubility of sirolimus was identified. Among the carriers tested, HPMC and SLS gave most improved drug solubility, resulting in selecting them as a suitable polymer and surfactant, respectively. Numerous solvent‐evaporated solid dispersions were prepared with various ratios of sirolimus, SLS, and HPMC via the spray‐drying system. Then, their aqueous solubility, dissolution, and crystallinity were evaluated. All generated formulations significantly enhanced the solubility and dissolution of drug when compared with the sirolimus powder. As the amount of HPMC and SLS were increased, the solubility and dissolution in solvent‐evaporated solid dispersions were increased. Moreover, all the solid dispersions represented the amorphous form of drug. Among the solid dispersions evaluated, the solid dispersion consisted of sirolimus, HPMC, and SLS at the weight ratio of 1:5:0.1 had most improved aqueous solubility (350.83 ± 11.92 vs. 0.003 ± 0.001 μg/mL) and dissolution (12.58 ± 1.31 vs. 1.13 ± 0.60%, at 240 min) compared with drug powder, respectively. This solvent‐evaporated solid dispersion appeared as the round‐shape and reduced the particle sizes. Thus, HPMC and SLS considerably affected the solubility and dissolution. Furthermore, this novel solvent‐evaporated solid dispersion would be a potential candidate for oral preparation of sirolimus.
机译:这项研究的目的是研究羟丙基甲基纤维素(HPMC)和十二烷基硫酸钠(SLS)对水溶性差的西罗莫司在溶剂蒸发的固体分散体中的溶解度,溶解度和结晶度的影响。为了选择合适的载体,确定了载体对西罗莫司溶解度的影响。在测试的载体中,HPMC和SLS改善了药物溶解度,因此分别选择它们作为合适的聚合物和表面活性剂。通过喷雾干燥系统制备了各种比例的西罗莫司,SLS和HPMC的溶剂蒸发的固体分散体。然后,评估它们的水溶性,溶解性和结晶性。与西罗莫司粉末相比,所有产生的制剂均显着增强了药物的溶解性和溶解性。随着HPMC和SLS含量的增加,在溶剂蒸发的固体分散体中的溶解度和溶解度也会增加。此外,所有固体分散体均代表药物的无定形形式。在所评估的固体分散体中,由西罗莫司,HPMC和SLS组成的固体分散体,其重量比为1:5:0.1,其水溶性最高(350.83±11.92对0.003±0.001μg/ mL),溶解度最大(12.58±与药物粉末相比,在240分钟时分别为1.31对1.13±0.60%)。这种溶剂蒸发的固体分散体呈圆形并减小了粒径。因此,HPMC和SLS极大地影响了溶解度和溶解度。此外,这种新型的溶剂挥发的固体分散体将成为西罗莫司口服制剂的潜在候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号